BPG is committed to discovery and dissemination of knowledge
Translational Research
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2026; 18(11): 125467
Published online Nov 27, 2026. doi: 10.4254/wjh.125467
Non-cancer mortality in hepatocellular carcinoma: Population-based competing-risk study
Yi Yang, Feng Liu, Xiao-Dong Chen, Lian-Lu Jiang
Yi Yang, Lian-Lu Jiang, Department of Hepatobiliary, Pancreatic and Splenic Surgery, First Affiliated Hospital of Hunan College of TCM, Zhuzhou 412000, Hunan Province, China
Feng Liu, Xiao-Dong Chen, Department of General Surgery, The People’s Hospital of Wuchuan, Zunyi 564300, Guizhou Province, China
Author contributions: Yang Y made substantial intellectual contributions to the critical revision and finalization of the manuscript; Liu F contributed to the conceptualization of the study, formal analysis, methodology, software, visualization, and wrote the original draft; Yang Y, Liu F, and Chen XD performed data curation; Yang Y and Chen XD conducted investigation and validation; Yang Y, Liu F, Chen XD, and Jiang LL were responsible for writing, reviewing and editing the manuscript; Jiang LL contributed to the conceptualization of the study, methodology, project administration and supervision; and all authors reviewed and approved the final manuscript.
AI contribution statement: No artificial intelligence or AI-assisted technologies were used in this study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Lian-Lu Jiang, MM, Attending Physician, Department of Hepatobiliary, Pancreatic and Splenic Surgery, First Affiliated Hospital of Hunan College of TCM, No. 571 Renmin Middle Road, Zhuzhou 412000, Hunan Province, China. jiexiu666@gmail.com
Received: July 8, 2026
Revised: August 5, 2026
Accepted: October 8, 2026
Published online: November 27, 2026
Processing time: 135 Days and 11.1 Hours
Abstract
BACKGROUND

Deaths unrelated to hepatocellular carcinoma (HCC) may be clinically relevant when patients survive long enough for age, chronic liver disease, cardiovascular disease, infection, and other conditions to influence mortality. Standard survival analyses may misrepresent this risk as HCC death precludes subsequent non-HCC death.

AIM

To estimate the cumulative incidence of non-HCC death and identify how its adjusted associations change during follow-up in a population-based HCC cohort.

METHODS

We analyzed 31274 adults with first primary HCC diagnosed during 2010-2015 in the Surveillance, Epidemiology, and End Results 17-registry database. Non-HCC death was the event of interest and HCC death was the competing event. Cumulative incidence functions were compared using Gray’s test. The primary regression used 19748 complete cases with known stage, tumor size, and alpha-fetoprotein status. Proportional subdistribution hazards were assessed with covariate-by-log(1 + time) terms. As the global assumption was violated, adjusted subdistribution hazard ratios were reported at 12 months, 36 months, and 60 months. A full-cohort missing-category Fine-Gray model and a cause-specific Cox model were sensitivity analyses.

RESULTS

During a reverse Kaplan-Meier median follow-up of 97 months [95% confidence interval (CI): 96-99], 22290 patients died from HCC and 3880 died from non-HCC causes; non-HCC deaths comprised 14.8% of all deaths. The cumulative incidence of non-HCC death was 6.2% (95%CI: 6.0%-6.5%) at 12 months, 9.8% (95%CI: 9.4%-10.1%) at 36 months, and 11.2% (95%CI: 10.8%-11.5%) at 60 months. The proportional subdistribution hazards assumption was rejected (global Wald χ2 = 836.6, 21 df, P < 0.001). For age 75 years or older vs 18-49 years, adjusted subdistribution hazard ratios increased from 1.33 (95%CI: 1.15-1.53) at 12 months to 1.74 (95%CI: 1.40-2.17) at 60 months. Advanced stage and larger tumors showed lower subdistribution hazards but not consistently lower cause-specific hazards, a pattern compatible with dominant competing HCC mortality. Associations with recorded surgery and chemotherapy crossed the null over time and cannot be interpreted as treatment effects.

CONCLUSION

Non-HCC death accounted for approximately one in seven deaths after HCC diagnosis. Its associations were time dependent, and a single constant subdistribution hazard ratio obscured clinically important changes during follow-up. The findings support competing-risk assessment and continued management of non-cancer health risks, while treatment comparisons remain vulnerable to selection and survivor bias.

Keywords: Hepatocellular carcinoma; Non-cancer mortality; Competing risks; Fine-Gray model; Surveillance, Epidemiology, and End Results; Time-varying effects

Core Tip: Among 31274 patients with hepatocellular carcinoma (HCC), 3880 non-HCC deaths represented 14.8% of all deaths. The proportional subdistribution hazards assumption was strongly violated; therefore, adjusted subdistribution hazard ratios were estimated at 12 months, 36 months, and 60 months rather than summarized by one constant value. Older age remained associated with higher non-HCC mortality, whereas apparent associations for tumor burden and treatment reflected competing HCC death, patient selection, and changing risk sets. These registry associations should not be read as causal treatment effects.

Write to the Help Desk